Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chubb
CB
|
+$1.32B |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$988M |
| 3 |
Intuitive Surgical
ISRG
|
+$780M |
| 4 |
RTX Corp
RTX
|
+$739M |
| 5 |
Amazon
AMZN
|
+$706M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CB
CHUBB CORPORATION
CB
|
+$2.39B |
| 2 |
JPMorgan Chase
JPM
|
+$1.48B |
| 3 |
GMCR
KEURIG GREEN MTN INC
GMCR
|
+$1.19B |
| 4 |
Wells Fargo
WFC
|
+$1.17B |
| 5 |
Apple
AAPL
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.15% |
| 2 | Financials | 13.85% |
| 3 | Technology | 13.69% |
| 4 | Consumer Discretionary | 12.66% |
| 5 | Communication Services | 10.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Teva Pharmaceuticals
TEVA
$40.4B
| $4.17B | 0.58% |
77,936,856
-7,391,035
| -9% | -$434M |
|
27
Procter & Gamble
PG
$340B
| $3.89B | 0.54% |
47,269,365
-375,639
| -0.8% | -$30.3M |
|
28
Tesla
TSLA
$1.18T
| $3.76B | 0.52% |
245,521,560
+45,790,110
| +23% | +$602M |
|
29
Bank of America
BAC
$429B
| $3.76B | 0.52% |
277,960,790
-24,131,347
| -8% | -$326M |
|
30
Citigroup
C
$213B
| $3.74B | 0.52% |
89,634,058
+162,029
| +0.2% | +$6.77M |
|
31
Bristol-Myers Squibb
BMY
$129B
| $3.73B | 0.52% |
58,392,548
+8,337,135
| +17% | +$526M |
|
|
AGN
32
DELISTED
Allergan plc
AGN
| $3.62B | 0.5% |
13,492,060
-1,960,903
| -13% | -$561M |
|
33
TJX Companies
TJX
$179B
| $3.58B | 0.5% |
91,422,474
+2,755,970
| +3% | +$100M |
|
34
Boston Scientific
BSX
$68.4B
| $3.56B | 0.49% |
189,045,221
+16,811,369
| +10% | +$295M |
|
|
35
Chubb
CB
$140B
| $3.52B | 0.49% |
29,561,557
+11,474,092
| +63% | +$1.32B |
|
36
Biogen
BIIB
$30.9B
| $3.51B | 0.49% |
13,493,064
+567,069
| +4% | +$150M |
|
37
Danaher
DHR
$138B
| $3.3B | 0.46% |
51,809,850
-5,562,794
| -10% | -$332M |
|
38
Adobe
ADBE
$105B
| $3.2B | 0.44% |
34,093,284
+2,809,944
| +9% | +$244M |
|
39
Colgate-Palmolive
CL
$74.8B
| $3.17B | 0.44% |
44,929,099
-32,217
| -0.1% | -$2.14M |
|
|
40
Regeneron Pharmaceuticals
REGN
$72.9B
| $3.11B | 0.43% |
8,621,553
+2,398,461
| +39% | +$988M |
|
41
US Bancorp
USB
$97.9B
| $3.1B | 0.43% |
76,357,680
-12,626,480
| -14% | -$504M |
|
42
AT&T
T
$164B
| $2.98B | 0.41% |
100,734,457
+7,077,684
| +8% | +$196M |
|
|
CELG
43
DELISTED
Celgene Corp
CELG
| $2.95B | 0.41% |
29,486,060
-1,677,940
| -5% | -$173M |
|
44
Broadcom
AVGO
$1.76T
| $2.95B | 0.41% |
190,741,900
+19,011,380
| +11% | +$257M |
|
45
NVIDIA
NVDA
$4.6T
| $2.9B | 0.4% |
3,251,947,880
+23,999,960
| +0.7% | +$18.3M |
|
46
Estee Lauder
EL
$30.4B
| $2.79B | 0.39% |
29,611,681
+629,923
| +2% | +$56.2M |
|
47
AutoZone
AZO
$51.3B
| $2.75B | 0.38% |
3,445,793
+154,534
| +5% | +$117M |
|
48
SLB Ltd
SLB
$72.7B
| $2.67B | 0.37% |
36,180,741
+3,988,921
| +12% | +$281M |
|
49
Qualcomm
QCOM
$164B
| $2.67B | 0.37% |
52,160,462
-8,524,466
| -14% | -$416M |
|
50
Cisco
CSCO
$443B
| $2.64B | 0.37% |
92,876,647
+11,556,021
| +14% | +$297M |
|
Similar funds
Fidelity Investments's Q1 2016 Portfolio in Review
As of Q1 2016, Fidelity Investments held 2,854 positions worth $723B, down 2.8% from $743B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Fidelity Investments's Q1 2016 filing shows 124 new, 1,114 increased, 1,111 reduced and 199 closed positions. Its largest new stake was Cullen/Frost Bankers: 4,980,056 shares worth $274M. The largest sale was CHUBB CORPORATION, an estimated $2.39B.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
- Fidelity Investments's largest Q1 2016 buy was Cullen/Frost Bankers: 4,980,056 shares worth $274M.
- Fidelity Investments added most to Chubb in Q1 2016, an estimated $1.32B increase.
- Fidelity Investments's biggest Q1 2016 reduction was JPMorgan Chase, cutting an estimated $1.48B.
- Fidelity Investments fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $2.39B.
- Fidelity Investments's ten largest holdings make up 15% of its $723B portfolio in Q1 2016.
- Fidelity Investments opened 124 new positions and closed 199 in Q1 2016.
- Fidelity Investments's portfolio value fell 2.8% quarter-over-quarter to $723B.
Based on Fidelity Investments's 13F filing for Q1 2016, filed 16 May 2016.